stockportfolio.pro
Stocks / GMED vs IONS
GMED vs IONS
Globus Medical, Inc. and Ionis Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
IONS is the larger company ($12.2B vs $11.0B). On the fundamentals, GMED grows revenue faster (30.1% vs 5.3%); GMED earns a higher net margin (18.3% vs -40.4%); GMED has the stronger return on equity (11.8% vs -78.0%). Full numbers below — the stronger figure on each row is in green.
| Globus Medical, Inc. (GMED) | Ionis Pharmaceuticals, Inc. (IONS) | |
|---|---|---|
| Market cap | $11.0B | $12.2B |
| Revenue (latest FY) | $2.94B | $943.71M |
| Net income (latest FY) | $537.87M | $-381.39M |
| Revenue growth (5y CAGR) | 30.1% | 5.3% |
| Net margin | 18.3% | -40.4% |
| Return on equity | 11.8% | -78.0% |
| P/E ratio | 18.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 3 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full GMED vs IONS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open GMED's full financials → Open IONS's full financials →More comparisons
Frequently asked questions
Which is bigger, GMED or IONS?
Ionis Pharmaceuticals, Inc. is larger by market capitalization — $12.2B versus $11.0B.
Which grows faster, GMED or IONS?
Over the last five fiscal years, Globus Medical, Inc. grew revenue faster — 30.1%/yr versus 5.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
GMED fundamentals → · IONS fundamentals → · All 1,500+ companies → · Free screener →